Single-cell Analysis Market Analysis, Size, Growth, Share, Trend, Outlook & Forecast to 2028
Single-cell Analysis Market Growth & Trends The global single-cell analysis market size is expected to reach USD 6.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.0% from 2021 to 2028. Expeditious technological advancements over the years have enabled a comprehensive analysis of transcriptome and genome in an individual cell. Single-cell technology helps in assessing cellular heterogeneity and aids in the analysis of pathways and processes at the molecular level. This technology is evolving at a rapid pace with applications in oncology, immunology, and others. Moreover, the introduction of advanced devices that simplify transcriptomic and proteomics procedures is driving the market. Advances in single-cell RNA sequencing (scRNAseq) allow researchers to thoroughly investigate unexplored rare cell types. The development of the microfluidics method has significantly broadened the implementation of single-cell genomic/transcriptomic analysis in the biomedical field. A substantial number of microfluidic devices have been modified for cell dissociation and tissue digestion. Browse full report with Table of Content (PDF with All Related Graph and Chart) @: https://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market
The increasing number of research publications is representative of the increasing investment flow in R&D in this market. As the R&D activities are the base of innovation, these investments signify a healthy growth possibility for this market. Moreover, researchers are engaged in assessing spatial heterogeneity in gene expression profiles at a single cellular level; thus, are anticipated to boost the uptake of consumables and instruments for the analysis. Single-cell Analysis Market Report Highlights
The consumables segment accounted for the largest revenue share due to the high adoption and demand of products offered under this segment Given the wide availability of different forms of reagents, this segment is responsible for constant revenue generation Owing to the high-end features and the technically advanced analytical options, automated instruments contributed to maximum revenue share The oncology segment is majorly benefited by the advancements in single-cell analysis methods To avoid risks associated with cancer therapy, single-cell analysis techniques are being heavily adopted for cancer genomics There is increasing demand for prenatal diagnosis and non-invasive techniques for the detection of single-gene disorders associated with the fetus
This has increased the adoption of single-cell analysis for prenatal diagnosis
Single-cell analysis is being widely employed by various end-users, ranging from academic research institutes to biotechnology and pharmaceutical companies
Academic and research institutes held a significant share due to wide usage across various studies
North America dominated the 2020 global market owing to the increasing R&D of robust therapies and disease diagnosis
Asia-Pacific is projected to witness the fastest CAGR, with India and China at the forefront
Thermo Fisher Scientific, QIAGEN NV, Illumina Inc., Merck Millipore, BGI, Fluidigm Corporation, and Bio-Rad Laboratories are some prominent entities in this space.
Companies have focused on the development of new innovative products to gain a competitive advantage
For Requesting a Sample Copy of This Report, Please Visit @
https://www.grandviewresearch.com/industry-analysis/single-cell-analysis-market/request/rs1
Single-cell Analysis Market Segmentation
Grand View Research has segmented the global single-cell analysis market on the basis of product, application, workflow, end-use, and region: Single Cell Analysis Product Outlook (Revenue, USD Million, 2017 - 2028) Consumables
o
Reagents
o
Assay Kits
o
Microscope
o
Hemocytometers
o
Flow Cytometers
o
NGS Systems
o
PCR
o
High Content Screening Systems
o
Cell Microarrays
o
Single Live Cell Imaging
o
Automated Cell Counters
Instruments
Single Cell Analysis Application Outlook (Revenue, USD Million, 2017 - 2028) Cancer
Immunology
Neurology
Stem cell
Non-invasive prenatal diagnosis
In-vitro fertilization
Others
Single Cell Analysis Workflow Outlook (Revenue, USD Million, 2017 - 2028) Single-cell isolation & Library Preparation
Downstream Analysis
Data Analysis
Single Cell Analysis End-use Outlook (Revenue, USD Million, 2017 - 2028) Academic & Research Laboratories
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Others
Single Cell Analysis Regional Outlook (Revenue, USD Million, 2017 - 2028) North America
o
U.S.
o
Canada
o
Germany
o
U.K.
o
France
o
Italy
o
Spain
o
China
o
India
o
Japan
o
South Korea
Europe
Asia Pacific
Latin America o
Brazil
o
Mexico
Middle East & Africa (MEA) o
South Africa
o
Saudi Arabia
List of Key Players of Single-cell Analysis Market Thermo Fisher Scientific
QIAGEN NV
Illumina Inc.
Bio-Rad Laboratories
10x Genomics Inc.
Novogene Corporation
BGI
Fluidigm Corporation
Merck Millipore
Becton, Dickinson & Company
Inquire more or share questions if any before the purchase on this report @ https://www.grandviewresearch.com/inquiry/2975/ibb
About Grand View Research Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Grand View Research, Inc. – Market Research And Consulting.
| Grand View Research, Inc.